What the company does
GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally. It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect; Kenhancer plaster for anti-inflammatory; and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief. The company also offers Albumin-GCC injection (inj.) for hypoalbuminemia and shock in acute hemorrhage, as well as low synthesis of albumin; Antithrombin-III (AT-III) inj. for hereditary antithrombin-III deficiency; Facnyne inj. for hemophilia B; Fibrinogen to treat hypofibrinogenemia and afibrinogenemia; Gamma Globulin for hypogammaglobulinemia and agammaglobulinemia; GCFLU …
What the weekly tape is saying
006280 closed the latest completed week at 126,400 KRW. The 4-week return is -8.9% and the 12-week return is -13.1%. Trend Signal is inactive, Market Dynamics is -1.08. Setup signature: Risk-first tape with a 21/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 148,867 KRW
- Vs Trend Line
- -15.1%
- Fair Value
- 130,623 KRW
- Vs Fair Value
- -3.2%
- 52W High
- 181,974 KRW
- 52W Low
- 117,800 KRW
- Drawdown
- -30.5%
- Range Position
- 13.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 26
- 52W Active Breadth
- 50.0%
- Sector Scope
- KR Healthcare
- Sector Rank
- 33 of 63
- Sector Percentile
- 48.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 16 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 10 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.08
- 4W MD Change
- -14.0%
- Relative Strength
- -52.19
- 4W RS Change
- -11.2%
- Expectation
- Positive
- Probability
- 58.01%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 229.4K
- 13W Average
- 260.7K
- 52W Average
- 260.2K
- Vs 13W
- 0.9x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.1%
- 52W Volatility
- 5.2%
- Upside Weeks
- 26
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 3.5% / -3.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 1571.6B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 126,400 KRW | -0.4% | 148,867 KRW | 130,623 KRW | -1.08 | -52.19 | 229.4K | Off |
| 5 Jun 2026 | 126,900 KRW | -10.3% | 149,254 KRW | 130,527 KRW | -0.89 | -53.06 | 225.0K | Off |
| 29 May 2026 | 141,400 KRW | 1.7% | 149,262 KRW | 130,479 KRW | -0.80 | -50.55 | 547.1K | Off |
| 22 May 2026 | 139,000 KRW | 0.2% | 148,829 KRW | 130,363 KRW | -0.94 | -48.38 | 309.0K | Off |
| 15 May 2026 | 138,700 KRW | 0.4% | 148,446 KRW | 130,261 KRW | -0.95 | -46.96 | 601.4K | Off |
| 8 May 2026 | 138,100 KRW | 0.7% | 148,054 KRW | 130,159 KRW | -1.02 | -48.02 | 201.5K | Off |
| 1 May 2026 | 137,100 KRW | -4.1% | 147,747 KRW | 130,062 KRW | -1.01 | -42.22 | 170.3K | Off |
| 24 Apr 2026 | 142,900 KRW | -5.5% | 147,543 KRW | 129,968 KRW | -1.00 | -39.53 | 194.8K | Off |
| 17 Apr 2026 | 151,200 KRW | 4.8% | 147,126 KRW | 129,820 KRW | -1.03 | -33.97 | 144.2K | Off |
| 10 Apr 2026 | 144,300 KRW | 2.6% | 146,420 KRW | 129,640 KRW | -1.11 | -34.20 | 190.2K | Off |
| 3 Apr 2026 | 140,600 KRW | -6.0% | 146,032 KRW | 129,558 KRW | -1.02 | -30.94 | 200.8K | Off |
| 27 Mar 2026 | 149,500 KRW | 2.8% | 145,668 KRW | 129,474 KRW | -0.79 | -28.28 | 162.1K | On |
| 20 Mar 2026 | 145,441 KRW | -3.5% | 144,965 KRW | 129,275 KRW | -0.25 | -35.04 | 213.8K | On |
| 13 Mar 2026 | 150,688 KRW | 0.1% | 144,428 KRW | 129,068 KRW | 0.24 | -29.94 | 199.3K | On |